About
Sustainogaine Outcomes is a newly launched independent information company helping people understand Long-term Ibogaine Outcomes: Follow-up Cases. Our aim is to provide clear, evidence-first summaries and organizational context so readers can find, assess, and compare follow-up case material without encountering marketing or clinic claims.
Our editorial approach
We assemble material with an emphasis on traceability: primary case notes, registries, peer-reviewed follow-ups, and public data are preferred over secondary summaries. Where appropriate we note study design, follow-up duration, and limitations so readers can judge applicability for themselves.
To support verification we link directly to original sources and to recognized repositories; for claims about methodology we reference established standards such as the CONSORT guidance on reporting clinical follow-up (https://en.wikipedia.org/wiki/CONSORT) and general best practices in research transparency from university resources like the University of Oxford's research guidelines (https://www.ox.ac.uk).
Editorially independent: we do not provide medical care, treatment referrals, or legal advice. See our disclosure in the footer for the full statement.
Sourcing and vetting
We prioritize sources that allow independent verification: registry entries, open-access journal reports, and institutional repositories. When summarizing follow-up cases, we record follow-up intervals and note potential confounders described by original authors.
For transparency about clinical trial and registry data we cross-check entries with established registries and dataset portals, using authoritative sources such as government health repositories when available (for example, the U.S. National Library of Medicine's registry at https://clinicaltrials.gov provides structured trial records).
We also maintain editorial notes describing why a particular case was included or excluded from a synthesis, and we update those notes if new information emerges.
What we cover
Our remit is narrow and editorial: we compile and contextualize follow-up case material, methodological observations, and interpretive commentary. Content types include annotated case summaries, timelines of follow-up assessments, and plain‑language summaries of methodological strengths and weaknesses.
If you are seeking treatment options or clinic referrals, this site is not a service provider; for clinical contact you should consult licensed providers or local health services. For general background on follow-up research methods you may find an overview at Wikipedia's article on follow-up studies helpful (https://en.wikipedia.org/wiki/Follow-up_(medicine)).
Who this is for
This resource is intended for people interested in Long-term Ibogaine Outcomes: Follow-up Cases — including independent researchers, clinicians seeking organized references, and members of the public comparing follow-up evidence. If you arrived via an external referral, our homepage contains the site’s central navigation and summaries that orient new readers; you can return to the site's main overview at Sustainogaine Outcomes' front page to explore topic hubs and recent updates.
Editorial principles
- Independence: No clinical services are offered and no commercial treatment endorsements are published.
- Traceability: Sources are linked and inclusion rationale is recorded.
- Clarity: Summaries aim for plain-language descriptions of follow-up intervals and limitations.
- Accuracy: We correct or annotate content when reliable updates become available.
Links, verification and related resources
When we point to external resources we favor stable, citable pages. For example, readers exploring treatment provider directories sometimes look to independent directories such as where to do ibogaine treatment for clinic listings; in our editorial pages we link to such directories only to contextualize treatment availability, not to recommend providers.
We also reference academic and institutional pages to support editorial claims; for example, methodological checklists and reporting standards are often cited from university guidance and public health agency pages such as the U.S. National Institutes of Health (https://www.nih.gov) when discussing research transparency.
If you need curated assistance with interpreting case summaries, our Services page describes non-clinical editorial and data-curation work we offer; visit the services overview for details on how we prepare structured summaries and literature maps.
Common questions
- Is Sustainogaine Outcomes a clinic?
- No. Sustainogaine Outcomes is an independent information company and is not a clinic, treatment provider, or licensed medical practice.
- How do you choose which follow-up cases to summarize?
- We favor primary reports and registries with documented follow-up intervals and explicit outcome measures; when inclusion is uncertain we add an editorial note explaining limitations and any potential conflicts.
- Can I request that you summarize a paper or case series?
- We describe editorial services on our services page including commissioned summaries and data organization; these are editorial products, not clinical consultations, and are delivered as curated reports.
Independent by design
Sustainogaine Outcomes is independently published to preserve editorial objectivity about Long-term Ibogaine Outcomes: Follow-up Cases. We do not provide medical or legal advice; readers should consult licensed professionals for clinical decisions. For transparency and to reduce bias we publish our editorial principles and link to primary sources wherever possible.
Where appropriate we also include links to recognized third-party resources and registries to help readers verify claims; examples of such authoritative sources include government health portals and university guidance pages cited earlier in the text.